Hemoglobin Nevers [alpha 2 beta 2130(H8)Tyr----Ser]; a new silent variant found in France

Human exposure to persistent organic pollutants in Switzerland: The role of diet, age, smoking, and body composition.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2025

A microsimulation model based on healthcare pathways to estimate the impact of COVID-19 pandemic-induced delays on breast cancer mortality.

Journal of clinical epidemiology·2025

Deciphering Pain Experience in Adult Patients With Sickle Cell Disease: A Network Analysis of Pain-Related Factors in a Single French Sickle Cell Centre.

European journal of pain (London, England)·2025

Evaluation of a prophylactic transfusion program on obstetric outcomes in pregnant women with sickle cell disease: A single centre retrospective cohort study.

European journal of obstetrics, gynecology, and reproductive biology·2023

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2022

Assessment of physicians' resilience level during the COVID-19 pandemic.

Translational psychiatry·2021

Metabolomic and Proteomic Profiling of Vaso-Occlusive Crises in Sickle Cell Disease: Current Evidence and Future Perspectives.

Hemoglobin·2026

Evaluation of a Customized RDB-FTH Panel for β-Globin Variants in a Malaysian Tertiary Center.

Hemoglobin·2026

CRISPR-Based Mediated Reactivation of Fetal Hemoglobin as a Therapeutic Strategy for Hemoglobinopathies: Evidence from Preclinical to Clinical Trials in Sickle Cell Disease and β-Thalassemia.

Hemoglobin·2026

Genotype-Specific Hematologic Signatures Across α-Globin Defect Categories in α-Thalassemia.

Hemoglobin·2026

Mapping the Management-to-Cure Transition in Thalassemia Research: Semantic Topic Modeling of 17,651 Publications Across Three Decades.

Hemoglobin·2026

Uncovering the True Genotype: Unusually Severe Sickle Cell Disease in a Child with an Initial HbSC Diagnosis.

Hemoglobin·2026

Characterisation of the Novel HLA-DQA1*04:01:11 Allele by Next-Generation Sequencing.

HLA·2026

Characterisation of the Novel HLA-DQB1*03:612 Allele by Sequencing-Based Typing.

HLA·2026

Identification of a New HLA-DRB5 Allele in a Chinese Han Individual, HLA-DRB5*01:01:17.

HLA·2026

The Novel HLA-DPB1*1903:01 Allele Was Likely Generated by a Recombination Event.

HLA·2026

Characterisation of the Novel HLA-C*16:01:53 Allele by Next-Generation Sequencing.

HLA·2026

Identification of the Novel HLA-F*01:37 Allele Using PolyseqOne Sequencing.

HLA·2026

Related Experiment Videos

Hemoglobin Nevers [alpha 2 beta 2130(H8)Tyr----Ser]; a new silent variant found in France

Related Concept Videos

Human exposure to persistent organic pollutants in Switzerland: The role of diet, age, smoking, and body composition.

A microsimulation model based on healthcare pathways to estimate the impact of COVID-19 pandemic-induced delays on breast cancer mortality.

Deciphering Pain Experience in Adult Patients With Sickle Cell Disease: A Network Analysis of Pain-Related Factors in a Single French Sickle Cell Centre.

Evaluation of a prophylactic transfusion program on obstetric outcomes in pregnant women with sickle cell disease: A single centre retrospective cohort study.

Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.

Assessment of physicians' resilience level during the COVID-19 pandemic.

Metabolomic and Proteomic Profiling of Vaso-Occlusive Crises in Sickle Cell Disease: Current Evidence and Future Perspectives.

Evaluation of a Customized RDB-FTH Panel for β-Globin Variants in a Malaysian Tertiary Center.

CRISPR-Based Mediated Reactivation of Fetal Hemoglobin as a Therapeutic Strategy for Hemoglobinopathies: Evidence from Preclinical to Clinical Trials in Sickle Cell Disease and β-Thalassemia.

Genotype-Specific Hematologic Signatures Across α-Globin Defect Categories in α-Thalassemia.

Mapping the Management-to-Cure Transition in Thalassemia Research: Semantic Topic Modeling of 17,651 Publications Across Three Decades.

Uncovering the True Genotype: Unusually Severe Sickle Cell Disease in a Child with an Initial HbSC Diagnosis.

Characterisation of the Novel HLA-DQA1*04:01:11 Allele by Next-Generation Sequencing.

Characterisation of the Novel HLA-DQB1*03:612 Allele by Sequencing-Based Typing.

Identification of a New HLA-DRB5 Allele in a Chinese Han Individual, HLA-DRB5*01:01:17.

The Novel HLA-DPB1*1903:01 Allele Was Likely Generated by a Recombination Event.

Characterisation of the Novel HLA-C*16:01:53 Allele by Next-Generation Sequencing.

Identification of the Novel HLA-F*01:37 Allele Using PolyseqOne Sequencing.

Related Experiment Videos

Hemoglobin Nevers [alpha 2 beta 2130(H8)Tyr----Ser]; a new silent variant found in France

Related Concept Videos

Related Articles